About Axys Pharmaceuticals
Axys Pharmaceuticals is a Healthcare company based in San Francisco (United States) founded in 1998, and was acquired by Celera in June 2001. Protease-based drugs developed for cancer and autoimmune diseases. Its focus areas include Diversified Pharmaceuticals.
Company details
Axys Pharmaceuticals was established in 1998 in San Francisco, United States, with a focus on small molecule drugs targeting cancer and autoimmune disorders. Research efforts centered on proteases through a structure-based drug design platform. Partnerships were formed with Merck, Aventis, and Bayer AG for programs addressing osteoporosis, asthma, inflammatory diseases, and cardiovascular conditions. The company was acquired by Celera in 2001.
- Headquarters San Francisco, United States
- Stage Acquired
- SectorsHealthcare
- Website axyspharm.com
- Acquired by Celera (Jun 2001)
Funding Insights of Axys Pharmaceuticals
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Axys Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Axys Pharmaceuticals
Axys Pharmaceuticals has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, Quest Diagnostics and National Institute of General Medical Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Basic research is supported to advance medical sciences. | nigms.nih.gov | Bethesda, United States | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Molecular diagnostic products for disease detection and treatment are developed. | 1998 | celera.com | Los Angeles, United States |
Investor details for Axys Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Axys Pharmaceuticals
4 dated milestones of Axys Pharmaceuticals across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Axys Pharmaceuticals is founded.
- Funding First funding round.
- Funding Latest funding round, Grant,.
- Exit Acquired by Celera.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Axys Pharmaceuticals (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Axys Pharmaceuticals
Complete news archive for Axys Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axys Pharmaceuticals
Axys Pharmaceuticals was founded in 1998.
Axys Pharmaceuticals is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Axys Pharmaceuticals was established in 1998 in San Francisco, United States, with a focus on small molecule drugs targeting cancer and autoimmune disorders. Research efforts centered on proteases through a structure-based drug design platform. Partnerships were formed with Merck, Aventis, and Bayer AG for programs addressing osteoporosis, asthma, inflammatory diseases, and cardiovascular conditions. The company was acquired by Celera in 2001.
Axys Pharmaceuticals has 3 investors. Key investors include NIH, Quest Diagnostics, and National Institute of General Medical Sciences.
Yes. Axys Pharmaceuticals was acquired by Celera in June 2001.